Suppr超能文献

加强以病例为导向的同行评审在提高放射肿瘤学质量与安全方面的作用:执行摘要。

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary.

作者信息

Marks Lawrence B, Adams Robert D, Pawlicki Todd, Blumberg Albert L, Hoopes David, Brundage Michael D, Fraass Benedick A

机构信息

Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.

Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.

出版信息

Pract Radiat Oncol. 2013 Jul-Sep;3(3):149-156. doi: 10.1016/j.prro.2012.11.010. Epub 2013 Mar 16.

Abstract

This report is part of a series of white papers commissioned for the American Society for Radiation Oncology (ASTRO) Board of Directors as part of ASTRO's Target Safely Campaign, focusing on the role of peer review as an important component of a broad safety/quality assurance (QA) program. Peer review is one of the most effective means for assuring the quality of qualitative, and potentially controversial, patient-specific decisions in radiation oncology. This report summarizes many of the areas throughout radiation therapy that may benefit from the application of peer review. Each radiation oncology facility should evaluate the issues raised and develop improved ways to apply the concept of peer review to its individual process and workflow. This might consist of a daily multidisciplinary (eg, physicians, dosimetrists, physicists, therapists) meeting to review patients being considered for, or undergoing planning for, radiation therapy (eg, intention to treat and target delineation), as well as meetings to review patients already under treatment (eg, adequacy of image guidance). This report is intended to clarify and broaden the understanding of radiation oncology professionals regarding the meaning, roles, benefits, and targets for peer review as a routine quality assurance tool. It is hoped that this work will be a catalyst for further investigation, development, and study of the efficacy of peer review techniques and how these efforts can help improve the safety and quality of our treatments.

摘要

本报告是美国放射肿瘤学会(ASTRO)董事会委托撰写的一系列白皮书的一部分,是ASTRO“安全靶向运动”的一部分,重点关注同行评议作为广泛的安全/质量保证(QA)计划重要组成部分的作用。同行评议是确保放射肿瘤学中针对特定患者的定性且可能存在争议的决策质量的最有效手段之一。本报告总结了放射治疗中许多可能受益于同行评议应用的领域。每个放射肿瘤学机构都应评估所提出的问题,并开发改进方法,将同行评议的概念应用于其各自的流程和工作流程。这可能包括每日多学科(如医生、剂量师、物理学家、治疗师)会议,以审查正在考虑接受放射治疗或正在进行放射治疗计划的患者(如治疗意图和靶区勾画),以及审查已在接受治疗患者的会议(如图像引导的充分性)。本报告旨在阐明并拓宽放射肿瘤学专业人员对同行评议作为常规质量保证工具的意义、作用、益处和目标的理解。希望这项工作将成为进一步研究、开发和探讨同行评议技术功效以及这些努力如何有助于提高我们治疗安全性和质量的催化剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dde/3808744/4bc22c656909/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验